Open Label,Phase II Trial of MAB Dose Escalation OF Bicalutamide For Biochemical Failure In Prostate Cancer Patients. - No Study Results Posted

Open Label,Phase II Trial of MAB Dose Escalation OF Bicalutamide For Biochemical Failure In Prostate Cancer Patients. (CHICS)

This study is currently recruiting participants.

Study NCT00554086 Information provided by Canadian Urology Research Consortium

First Received: November 5, 2007 Last Updated: August 11, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	December 2010
Estimated Primary Completion Date:	September 2009 (Final data collection date for primary outcome measure)